Therefore, studies with larger sample sizes and accounting for triglyceride levels will be needed to document whether variation at the LPL locus are strongly associated with NAFLD and whether their effects are entirely mediated by triglyceride levels. The gene discussed is LPL; the disease is metabolic dysfunction-associated steatotic liver disease.